Analysis of expression and structure of the TSG101 gene in cervical cancer cells

International Journal of Molecular Medicine

Volumn 25, Issue 5, 2010, Pages 777-783

  Broniarczyk, Justyna ^a   Olejnik Schmidt, A K ^b   Luczak, M W ^c   Schmidt, M T ^b   Dabrowski, M ^a   Jozefiak A ^c   Kedzia, W ^c   Kwasniewska, A ^d   Gozdzicka Jozefiak A ^a  

^a ADAM MICKIEWICZ UNIVERSITY   (Poland)

^b POZNA UNIVERSITY OF LIFE SCIENCES   (Poland)

^c POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^d MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

Cervical cancer; Human papillomaviruses; Tumor suppressor gene

Indexed keywords

MESSENGER RNA; PROTEIN;

ADULT; AGED; ANIMAL CELL; ARTICLE; CARCINOGENESIS; CELL TRANSFORMATION; CLINICAL ARTICLE; CODING; CONTROLLED STUDY; DOWN REGULATION; EPIGENETICS; EPITHELIUM CELL; FEMALE; GENE EXPRESSION; GENE STRUCTURE; GENETIC ANALYSIS; HOMEOSTASIS; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN TISSUE; METHYLATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; REAL TIME POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM; SINGLE STRAND CONFORMATION POLYMORPHISM; TUMOR GENE; TUMOR SUSCEPTIBILITY GENE 101; UPREGULATION; UTERINE CERVIX CANCER; VIRUS INFECTION; WESTERN BLOTTING;

ADULT; AGED; ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; DNA-BINDING PROTEINS; ENDOSOMAL SORTING COMPLEXES REQUIRED FOR TRANSPORT; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMAN PAPILLOMAVIRUS 16; HUMANS; MICE; MIDDLE AGED; NIH 3T3 CELLS; POLYMORPHISM, SINGLE NUCLEOTIDE; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PROMOTER REGIONS, GENETIC; TRANSCRIPTION FACTORS; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 77951701765     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm_00000404     Document Type: Article

References (43)

1. Soliman PT, Slomovitz BM and Wolf JK: Mechanism of cervical cancer. Drug Discov Today 1: 253-258, 2004.
2. Zur Hausen H: Papillomaviruses in human cancers. Proc Assoc Am Physicians 111: 581-587, 1999.
3. Li L and Cohen SN: Tsg101: a novel tumor susceptibility gene isolated by controlled homozygous functional knockout of allelic loci in mammalian cells. Cell 85: 319-329, 1996. (Pubitemid 26160704)
4. Li L, Li X, Francke U and Cohen SN: The TSG101 tumor susceptibility gene is located in chromosome 11 band p15 and is mutated in human breast cancer. Cell 88: 143-154, 1997. (Pubitemid 27180338)
5. Singh RK, Dasgupta S, Bhattacharya N, Chunder N, Mondal R, Roy A, Mandal S, Roychowdhury S and Panda CK: Deletion in chromosome 11 and Bcl-1/Cyclin D1 alterations are independently associated with the development of uterine cervical carcinoma. J Cancer Res Clin Oncol 131: 395-406, 2005. (Pubitemid 40674625)
6. Wagner KU, Dierisseau P, Rucker EB, Robinson GW and Hennighausen L: Genomic architecture and transcriptional activation of the mouse and human tumor susceptibility gene TSG101: common types of shorter transcripts are true alternative splice variants. Oncogene 17: 2761-2770, 1998. (Pubitemid 28554235)
7. Wakaguri H, Yamashita R, Suzuki Y, Sugano S and Nakai K: DBTSS: database of transcription start sites, progress report. Nucleic Acids Res 36: D97-D101, 2007. (Pubitemid 351149703)
8. Liu RT, Huang CC, You HL, Chou FF, Hu CC, Chao FP, Chen CM and Cheng JT: Overexpression of tumor susceptibility gene TSG101 in human papillary thyroid carcinomas. Oncogene 21: 4830-4837, 2002.
9. Young TW, Mei FC, Rosen DG, Yang G, Li N, Liu J and Cheng X: Up-regulation of tumor susceptibility gene 101 protein in ovarian carcinomas revealed by proteomics analyses. Mol Cell Proteomics 6: 294-304, 2007. (Pubitemid 46359517)
10. Bennett NA, Pattillo RA, Lin RS, Hsieh CY, Murphy T and Lyn D: TSG101 expression in gynecological tumors: relationship to cyclin D1, cyclin E, p53 and p16 proteins. Cell Mol Biol 47: 1187-1193, 2001.
11. Carstens MJ, Krempler A, Triplett AA, Van Lohuizen M and Wagner KU: Cell cycle arrest and cell death are controlled by p53-dependent and p53-independent mechanisms in Tsg101-deficient cells. J Biol Chem 279: 35984-35994, 2004. (Pubitemid 39100606)
12. Koonin EV and Abagyan RA: TSG101 may be the prototype of a class of dominant negative ubiquitin regulators. Nat Genet 16: 330-331, 1997.
13. Ponting CP, Cai YD and Bork P: The breast cancer gene product TSG101: a regulator of ubiquitination? J Mol Med 75: 467-469, 1997.
14. Watanabe M, Yanagi Y, Masuhiro Y, Yano T, Yoshikawa H, Yanagisawa J and Kato S: A putative tumor suppressor, TSG101, acts as a transcriptional suppressor through its coiled-coil domain. Biochem Biophys Res Commun 245: 900-905, 1998. (Pubitemid 28414015)
15. Hittelman AB, Burakov D, Iniguez-Lluhi JA, Freedman LP and Garabedian MJ: Differential regulation of glucocorticoid receptor transcriptional activation via AF-1-associated proteins. EMBO J 18: 5380-5388, 1999. (Pubitemid 29465587)
16. Babst M, Odorizzi G, Estepa EJ and Emr SD: Mammalian tumor susceptibility gene 101 (TSG101) and the yeast homologue, Vps23p, both function in late endosomal trafficking. Traffic 1: 248-258, 2000.
17. Garrus JE, von Schwedler UK, Pornillos OW, Morham SG, Zavitz KH, Wang HE, Wettstein DA, Stray KM, Cote M, Rich RL, Myszka DG and Sundquist WI: Tsg101 and the vacuolar protein sorting pathway are essential for HIV-1 budding. Cell 107: 55-65, 2001. (Pubitemid 32972037)
18. Lu Q, Hope LW, Brasch M, Reinhard C and Cohen SN: TSG101 interaction with HRS mediates endosomal trafficking and receptor down-regulation. Proc Natl Acad Sci USA 100: 7626-7631, 2003. (Pubitemid 36760020)
19. Bache KG, Brech A, Mehlum A and Stenmark H: Hrs regulates multivesicular body formation via ESCRT recruitment to endosomes. J Cell Biol 162: 435-442, 2003. (Pubitemid 36988552)
20. Zhong Q, Chen Y, Jones D and Lee WH: Perturbation of TSG101 protein affects cell cycle progression. Cancer Res 58: 2699-2702, 1998. (Pubitemid 28311892)
21. Xie W, Li L and Cohen SN: Cell cycle-dependent subcellular localization of the TSG101 protein and mitotic and nuclear abnormalities associated with TSG101 deficiency. Proc Natl Acad Sci USA 95: 1595-1600, 1998. (Pubitemid 28103438)
22. Ruland J, Sirard C, Elia A, MacPherson D, Wakeham A, Li L, de la Pompa JL, Cohen SN and Mak TW: p53 accumulation, defective cell proliferation, and early embryonic lethality in mice lacking tsg101. Proc Natl Acad Sci USA 98: 1859-1864, 2001.
23. Krempler A, Henry MD, Triplett AA and Wagner KU: Targeted deletion of the Tsg101 gene results in cell cycle arrest at G1/S and p53-independent cell death. J Biol Chem 277: 43216-43223, 2002. (Pubitemid 35285707)
24. Wagner KU, Krempler A, Qi Y, Park K, Henry MD, Triplett AA, Riedlinger G, Rucker EB and Hennighausen L: Tsg101 is essential for cell growth, proliferation, and cell survival of embryonic and adult tissues. Mol Cell Biol 23: 150-162, 2003. (Pubitemid 36008509)
25. Tachezy R, Van Ranst MA, Cruz Y and Burk RD: Analysis of short novel human papillomavirus sequences. Biochem Biophys Res Commun 204: 820-827, 1994. (Pubitemid 24343994)
26. Schmidt M, Kedzia W and Gozdzicka-Józefiak A: Intratype HPV16 sequence variation within LCR of isolates from asymptomatic carriers and cervical cancers. J Clin Virol 23: 65-77, 2001. (Pubitemid 32930101)
27. Frith MC, Hansen U and Weng Z: Detection of cis-element clusters in higher eukaryotic DNA. Bioinformatics 17: 878-889, 2001. (Pubitemid 32998624)
28. Grabe N: AliBaba2: context specific identification of transcription factor binding sites. In Silico Biol 2: S1-S15, 2002. (Pubitemid 33138331)
29. Feng GH, Lih CJ and Cohen SN: TSG101 protein steady-state level is regulated posttranslationally by an evolutionarily conserved COOH-terminal sequence. Cancer Res 60: 1736-1741, 2000.
30. Zhu G, Gilchrist R, Borley N, Chang HW, Morgan M, Marshall JF, Camplejohn RS, Muir GH and Hart IR: Reduction of TSG101 protein has a negative impact on tumor cell growth. Int J Cancer 109: 541-547, 2004. (Pubitemid 38339644)
31. Razi M and Futter CE: Distinct roles for Tsg101 and Hrs in multivesicular body formation and inward vesiculation. Mol Biol Cell 17: 3469-3483, 2006. (Pubitemid 44156441)
32. Doyotte A, Russell MR, Hopkins CR and Woodman PG: Depletion of TSG101 forms a mammalian 'Class E' compartment: a multicisternal early endosome with multiple sorting defects. J Cell Sci 118: 3003-3017, 2005.
33. Sizemore N, Choo CK, Eckert RL and Rorke EA: Transcriptional regulation of the EGF receptor promoter by HPV16 and retinoic acid in human ectocervical epithelial cells. Exp Cell Res 244: 349-356, 1998. (Pubitemid 28480883)
34. O'Boyle JD, Proctor ML, Fong KM, Lin WM, Miller DS and Muller CY: Role of TSG101 in uterine cervix cancer. Gynecol Oncol 75: 401-405, 1999.
35. Seth A and Watson DK: ETS transcription factors and their emerging roles in human cancer. Eur J Cancer 41: 2462-2478, 2005. (Pubitemid 41540623)
36. Wang L, Wei D, Huang S, Peng Z, Le X, Wu TT, Yao J, Ajani J and Xie K: Transcription factor Sp1 expression is a significant predictor of survival in human gastric cancer. Clin Cancer Res 15: 6371-6380, 2003. (Pubitemid 38031822)
37. You HL, Eng HL, Hsu SF, Chen CM, Ye TC, Liao WT, Huang MY, Baer R and Cheng JT: A PKC-Sp1 signaling pathway induces early differentiation of human keratinocytes through upregulation of TSG101. Cell Signal 19: 1201-1211, 2007. (Pubitemid 46561557)
38. Laird PW and Jaenisch R: DNA methylation and cancer. Hum Mol Genet 3: 1487-1495, 1994.
39. Dueñas-González A, Lizano M, Candelaria M, Cetina L, Arce C and Cervera E: Epigenetics of cervical cancer. An overview and therapeutic perspectives. Mol Cancer 25: 4-38, 2005.
40. Herman JG, Jen J, Merlo A and Baylin SB: Hypermethyletion-associated inactivation indicates a tumor suppressor role for p15INK4B1. Cancer Res 56: 722-727, 1996. (Pubitemid 26060512)
41. Stirzaker C, Millar DS, Paul CL, Warnecke PM, Harisson I, Vincent PC, Frommer M and Clark SJ: Extensive DNA methylation spanning the RB promoter in retinoblastoma tumors. Cancer Res 57: 2229-2237, 1997. (Pubitemid 27247043)
42. Greger V, Passarge E, Höpping W, Messmer E and Horsthemke B: Epigenetic changes may contribute to the formation and spontaneous regression of retinoblastoma. Hum Genet 83: 155-158, 1989. (Pubitemid 19234564)
43. Chan TF, Su TH, Yeh KT, Chang JY, Lin TH, Chen JC, Yuang SS and Chang JG: Mutational, epigenetic and expressional analyses of caveolin-1 gene in cervical cancers. Int J Oncol 23: 599-604, 2003.